1. Home
  2. LIDR vs ACOG Comparison

LIDR vs ACOG Comparison

Compare LIDR & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$1.65

Market Cap

118.0M

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.85

Market Cap

129.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIDR
ACOG
Founded
2013
2000
Country
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
129.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIDR
ACOG
Price
$1.65
$5.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$18.00
AVG Volume (30 Days)
669.7K
63.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.07
N/A
Revenue Next Year
$2,660.98
$132.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$3.75
52 Week High
$6.44
$10.88

Technical Indicators

Market Signals
Indicator
LIDR
ACOG
Relative Strength Index (RSI) 42.92 54.23
Support Level $1.60 $4.80
Resistance Level $1.71 $5.99
Average True Range (ATR) 0.11 0.66
MACD 0.02 0.06
Stochastic Oscillator 59.40 81.88

Price Performance

Historical Comparison
LIDR
ACOG

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: